Beta Bionics
Logotype for Beta Bionics Inc

Beta Bionics (BBNX) investor relations material

Beta Bionics Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Beta Bionics Inc
Q4 2025 earnings summary17 Feb, 2026

Executive summary

  • Achieved $100.3 million in net sales for 2025, up 54% year-over-year, with Q4 net sales of $32.1 million, up 57% year-over-year.

  • Installed customer base grew 129% year-over-year to 35,011 users, with nearly 20,000 new users adopting the iLet in 2025.

  • Strategic product launches and integration milestones, including Bionic Circle, Color iLet, and Libre 3 Plus, supported market expansion.

  • R&D milestones included completion of first-in-human Phase 2a feasibility trial for the bihormonal system, with additional trials planned for H1 2026.

  • Pharmacy channel strategy drove significant adoption and access, with formulary agreements established with all major PBMs.

Financial highlights

  • Q4 2025 gross margin was 59%, up 179 basis points year-over-year; full year gross margin was 55.4%.

  • Q4 2025 operating expenses were $35.1 million; adjusted EBITDA loss for Q4 was ($10.5M), net loss ($13.5M).

  • Ended 2025 with $265 million in cash, cash equivalents, and investments.

  • Full year 2025 loss from operations was $71.7M, net loss $73.2M.

  • Sequential quarterly revenue growth and margin improvement observed throughout 2025.

Outlook and guidance

  • 2026 revenue guidance: $130–$135 million; gross margin expected between 55.5% and 57.5%.

  • 36%–38% of new patient starts in 2026 expected to be reimbursed through the pharmacy/PBP channel.

  • OpEx and CapEx to increase as a percentage of revenue, with investments in sales, marketing, and R&D (notably Mint and bihormonal system).

  • At least 20 new sales territories to be added in 2026, with most expansion in the first half.

  • Q1 2026 revenue and new patient starts expected to decline sequentially from Q4 2025, with revenue more weighted to first half of 2026.

PBP channel growth drivers for 2026
Bihormonal system: path to market timeline?
Installed base growth vs. new patient starts?
FDA warning letter: Q2 remediation on track?
Sales force expansion: Rationale for pace?
Gross margin drivers for 2026 cadence?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Beta Bionics earnings date

Logotype for Beta Bionics Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026
Beta Bionics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Beta Bionics earnings date

Logotype for Beta Bionics Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Beta Bionics Inc is a U.S.-based medical technology company focused on the development of autonomous insulin delivery systems for people with diabetes. The company is developing the iLet Bionic Pancreas, an all-in-one wearable device designed to automate blood glucose management using insulin or a combination of insulin and glucagon. Beta Bionics aims to improve the quality of life for individuals with type 1 diabetes through advanced, user-friendly technologies. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage